InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INM InMed Pharmaceuticals Inc

休市中 07-02 16:00:00 EDT

1.56

-0.03

-1.89%

盘后1.50

-0.06-4.04%

18:08 EDT

最高1.60	最低1.55	成交量3.32万
今开1.58	昨收1.59	日振幅3.14%
总市值517.00万	流通市值336.80万	总股本331.41万
成交额5.22万	换手率1.54%	流通股本215.90万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INM","market":"US","secType":"STK","nameCN":"InMed Pharmaceuticals Inc","latestPrice":1.56,"timestamp":1783022400000,"preClose":1.59,"halted":0,"volume":33198,"hourTrading":{"tag":"盘后","latestPrice":1.4969,"preClose":1.56,"latestTime":"18:08 EDT","volume":104,"amount":155.93,"timestamp":1783030136929,"change":-0.0631,"changeRate":-0.040449,"amplitude":0.040449},"delay":0,"changeRate":-0.018867924528301903,"floatShares":2159000,"shares":3314100,"eps":-2.532377,"marketStatus":"休市中","change":-0.03,"latestTime":"07-02 16:00:00 EDT","open":1.58,"high":1.6,"low":1.55,"amount":52176.167868,"amplitude":0.031447,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.532377,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.56,"preClose":1.59,"latestTime":"09:28 EDT","volume":6,"amount":9.3788994,"timestamp":1782998896094,"change":-0.03,"changeRate":-0.018868,"amplitude":0.011887},"postHourTrading":{"tag":"盘后","latestPrice":1.4969,"preClose":1.56,"latestTime":"18:08 EDT","volume":104,"amount":155.93,"timestamp":1783030136929,"change":-0.0631,"changeRate":-0.040449,"amplitude":0.040449},"volumeRatio":0.7237473183276621},"requestUrl":"/m/hq/s/INM","defaultTab":"news","newsList":[{"id":"1192836313","title":"交易完成后，InMed Pharmaceuticals合并公司备考股权价值约4.214亿美元（含私募配售）","url":"https://stock-news.laohu8.com/highlight/detail?id=1192836313","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192836313?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:09","pubTimestamp":1779192550,"startTime":"0","endTime":"0","summary":"根据最新披露，InMed Pharmaceuticals Inc（InMed Pharmaceuticals Inc）在完成相关交易后，合并公司的备考股权价值预计将达到约4.214亿美元。这一估值已将同时进行的私募配售所得资金纳入计算。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117049943","title":"InMed Pharmaceuticals：合并后公司股权结构揭晓，原股东预计持股约1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117049943","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117049943?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:02","pubTimestamp":1779192156,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc（InMed Pharmaceuticals）的股东们，在即将到来的企业合并中，预计将持有合并后新公司大约1.51%的股份。这一股权比例，勾勒出交易完成后公司所有权结构的关键轮廓。随着整合进程的推进，股东权益的重新分配成为市场关注的焦点。最终的股权构成，将对公司的未来治理与发展方向产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134404492","title":"InMed制药公司宣布支持INM-901阿尔茨海默病项目的积极数据——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1134404492","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134404492?lang=zh_cn&edition=full","pubTime":"2026-03-23 19:37","pubTimestamp":1774265841,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc近日通过提交给美国证券交易委员会（SEC）的文件，公布了其阿尔茨海默病治疗项目INM-901的积极研究数据。这一进展为该公司在神经退行性疾病领域的研发工作提供了重要支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145141774","title":"InMed Pharmaceuticals Inc 计划于2027年提交INM-901新药临床申请并启动一期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1145141774","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145141774?lang=zh_cn&edition=full","pubTime":"2026-03-23 19:36","pubTimestamp":1774265797,"startTime":"0","endTime":"0","summary":"根据最新提交的SEC文件显示，InMed Pharmaceuticals Inc已明确其研发时间表，公司目标在2027年完成INM-901的新药临床试验申请（IND）提交工作，并同步启动该药物的第一阶段临床实验。这一规划标志着其在药物研发领域的又一重要布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175620357","title":"InMed制药公司于3月4日确认并批准终止Baymedica商业运营的决定——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1175620357","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175620357?lang=zh_cn&edition=full","pubTime":"2026-03-07 06:03","pubTimestamp":1772834586,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新文件披露，InMed Pharmaceuticals Inc（INM）于3月4日正式确认并通过决议，将逐步终止其旗下Baymedica部门的商业运营。该决定标志着公司战略重心调整，未来资源将更集中于核心业务领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512818444","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512818444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512818444?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:02","pubTimestamp":1739980925,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时02分，Inmed Pharmaceuticals Inc.股票出现异动，股价急速上涨5.36%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为1.27%。其相关个股中，坎伯兰药业、Gelteq Limited、和黄医药涨幅较大，Petros Pharmaceuticals, Inc.、Painreform Ltd.、大自然药业较为活跃，换手率分别为39.87%、33.93%、9.89%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、坎伯兰药业、Painreform Ltd.，振幅分别为26.13%、23.03%、10.24%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200002059628dbbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200002059628dbbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510818309","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘快速上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510818309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510818309?lang=zh_cn&edition=full","pubTime":"2025-02-12 23:22","pubTimestamp":1739373736,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日23时22分，Inmed Pharmaceuticals Inc.股票出现波动，股价急速拉升5.52%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.21%。其相关个股中，Sunshine Biopharma Inc C/Wts 、吉利德科学、Evoke Pharma, Inc.涨幅较大，大自然药业、Quantum Biopharma Ltd.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为16.40%、8.85%、7.08%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Organigram Holdings Inc.、Cyclo Therapeutics, Inc.，振幅分别为28.47%、11.11%、10.30%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212232216abcc68e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212232216abcc68e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509202897","title":"Inmed Pharmaceuticals Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509202897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509202897?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:00","pubTimestamp":1738954831,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时00分，Inmed Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.08%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.74%。其相关个股中，Cyclo Therapeutics, Inc.、大自然药业、Alvotech C/Wts 涨幅较大，大自然药业、Cyclo Therapeutics, Inc.、Quantum Biopharma Ltd.较为活跃，换手率分别为1562.19%、246.34%、131.91%，振幅较大的相关个股有Cyclo Therapeutics, Inc.、Biofrontera Inc C/Wts 27/10/2026 、Cyclo Therapeutics Inc C/Wts 11/12/2025，振幅分别为62.34%、51.08%、47.28%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030031987ddadc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030031987ddadc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509287285","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大涨5.12%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509287285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509287285?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:00","pubTimestamp":1738767626,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时00分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速拉升5.12%。截至发稿，该股报3.29美元/股，成交量1.543万股，换手率2.13%，振幅1.92%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为1.55%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230027987b8149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230027987b8149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508013141","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘急速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508013141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508013141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:50","pubTimestamp":1738594255,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时50分，Inmed Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.52%。截至发稿，该股报2.91美元/股，成交量22.6394万股，换手率31.26%，振幅6.49%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.14%。其相关个股中，Medicus Pharma Ltd.、Im Cannabis Corp.、Incannex Healthcare Inc.涨幅较大，Inmed Pharmaceuticals Inc.、Painreform Ltd.、Cbdmd, Inc.较为活跃，换手率分别为31.43%、4.33%、2.81%，振幅较大的相关个股有Ironwood医药、Procaps Group, S.A.、Quantum Biopharma Ltd.，振幅分别为8.55%、7.51%、7.32%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032250559616ff50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032250559616ff50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508964087","title":"Inmed Pharmaceuticals Inc.盘中异动 快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508964087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508964087?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:51","pubTimestamp":1738338699,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时51分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速下跌5.15%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.86%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Journey Medical Corporation、艾伯维公司涨幅较大，Cbdmd, Inc.、Sonoma Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为8.28%、6.56%、3.35%，振幅较大的相关个股有Scilex Holding Company、苏轩堂、Cbdmd, Inc.，振幅分别为14.09%、12.54%、11.77%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123514098776952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123514098776952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507691620","title":"Inmed Pharmaceuticals Inc.盘中异动 急速下跌8.52%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507691620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507691620?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:59","pubTimestamp":1738252758,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时59分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速下跌8.52%。截至发稿，该股报3.22美元/股，成交量1.2247万股，换手率1.69%，振幅4.97%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为1.13%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235918a2346487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235918a2346487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507543035","title":"Inmed Pharmaceuticals Inc.盘中异动 急速跳水5.04%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507543035?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:30","pubTimestamp":1738081820,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时30分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报3.77美元/股，成交量3.49万股，换手率4.82%，振幅6.17%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体跌幅为0.35%。其相关个股中，Cbdmd, Inc.、Painreform Ltd.、Eton Pharmaceuticals, Inc.涨幅较大，Cbdmd, Inc.、Painreform Ltd.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为181.73%、18.71%、4.84%，振幅较大的相关个股有Cbdmd, Inc.、Painreform Ltd.、Durect Corporation，振幅分别为48.61%、13.35%、12.94%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129003020a2328744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129003020a2328744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506130546","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘大幅下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506130546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506130546?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:50","pubTimestamp":1737989427,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时50分，Inmed Pharmaceuticals Inc.股票出现异动，股价急速跳水5.21%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.55%。其相关个股中，Alpha Teknova, Inc.、Sunshine Biopharma Inc C/Wts 、苏轩堂涨幅较大，Painreform Ltd.、大自然药业、苏轩堂较为活跃，换手率分别为32.17%、5.84%、5.73%，振幅较大的相关个股有Alpha Teknova, Inc.、Petros Pharmaceuticals, Inc.、Painreform Ltd.，振幅分别为13.18%、7.90%、7.00%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272250289874b2d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272250289874b2d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","INM","TKNO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505011731","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大涨6.25%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505011731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505011731?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642666,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅拉升6.25%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体跌幅为0.27%。其相关个股中，Evoke Pharma, Inc.、Petros Pharmaceuticals, Inc.、Emergent Biosolutions Inc.涨幅较大，Inmed Pharmaceuticals Inc.、Incannex Healthcare Inc.、Painreform Ltd.较为活跃，换手率分别为7.60%、7.04%、1.26%，振幅较大的相关个股有惠普森医药、Incannex Healthcare Inc.、Emergent Biosolutions Inc.，振幅分别为5.81%、5.30%、3.68%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223106960e43ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223106960e43ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505726419","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大跌11.88%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505726419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505726419?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:31","pubTimestamp":1737556266,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时31分，Inmed Pharmaceuticals Inc.股票出现波动，股价快速下挫11.88%。截至发稿，该股报4.45美元/股，成交量21.4958万股，换手率29.68%，振幅0.00%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体跌幅为0.16%。其相关个股中，Gelteq Limited、Quantum Biopharma Ltd.、Kamada Ltd.涨幅较大，Gelteq Limited、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃，换手率分别为53.17%、29.68%、0.81%，振幅较大的相关个股有阿玛琳、Aquestive Therapeutics, Inc.、Canopy Growth Corporation，振幅分别为3.51%、3.41%、1.73%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223106a22bb124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223106a22bb124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271639","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大涨36.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271639?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:36","pubTimestamp":1737470191,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时36分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速拉升36.62%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.68%。其相关个股中，Inmed Pharmaceuticals Inc.、Evolus, Inc. Common Stock、Im Cannabis Corp.涨幅较大，Inmed Pharmaceuticals Inc.、大自然药业、Cbdmd, Inc.较为活跃，换手率分别为1859.59%、3.15%、2.61%，振幅较大的相关个股有Akanda Corp.、Flora Growth Corp.、Amneal Pharmaceuticals, Inc.，振幅分别为105.06%、104.15%、101.94%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223631960bba25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223631960bba25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504194916","title":"Inmed Pharmaceuticals Inc.盘中异动 大幅上涨5.11%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504194916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504194916?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:30","pubTimestamp":1737135029,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时30分，Inmed Pharmaceuticals Inc.股票出现异动，股价急速上涨5.11%。截至发稿，该股报4.73美元/股，成交量2.25万股，换手率3.11%，振幅7.11%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体跌幅为1.42%。其相关个股中，和黄医药、Medicus Pharma Ltd.、Quantum Biopharma Ltd.涨幅较大，Cbdmd, Inc.、大自然药业、Painreform Ltd.较为活跃，换手率分别为20.24%、13.91%、10.43%，振幅较大的相关个股有Cbdmd, Inc.、Alvotech C/Wts 、Aytu Biopharma, Inc.，振幅分别为21.41%、15.00%、12.44%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118013029986a3bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118013029986a3bbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503764031","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大涨7.11%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503764031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503764031?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:49","pubTimestamp":1736952555,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时49分，Inmed Pharmaceuticals Inc.股票出现异动，股价急速拉升7.11%。截至发稿，该股报4.37美元/股，成交量1773股，换手率0.24%，振幅0.73%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体涨幅为0.78%。其相关个股中，Therapeuticsmd, Inc.、Citius Oncology, Inc.、Avadel Pharmaceuticals Plc涨幅较大，大自然药业、Cbdmd, Inc.、Intra-Cellular Therapies Inc.较为活跃，换手率分别为13.33%、5.16%、1.58%，振幅较大的相关个股有苏轩堂、Journey Medical Corporation、Citius Oncology, Inc.，振幅分别为9.79%、8.58%、7.97%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152249159604b96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152249159604b96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503686549","title":"Inmed Pharmaceuticals Inc.盘中异动 下午盘股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503686549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503686549?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:14","pubTimestamp":1736885695,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时14分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.69%。截至发稿，该股报3.98美元/股，成交量2.5258万股，换手率3.49%，振幅8.29%。Inmed Pharmaceuticals Inc.股票所在的制药行业中，整体跌幅为3.80%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc是一家总部位于加拿大的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504145598663a60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504145598663a60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inmedpharma.com","stockEarnings":[{"period":"1week","weight":0.0331},{"period":"1month","weight":0.0263},{"period":"3month","weight":1.3009},{"period":"6month","weight":0.3929},{"period":"1year","weight":-0.4885},{"period":"ytd","weight":0.4717}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InMed Pharmaceuticals Inc.根据不列颠哥伦比亚省商业公司法，于1981年5月19日在不列颠哥伦比亚省注册成立。该公司是一家制药公司，正在开发一系列专有的小分子候选药物，这些候选药物是内源性CB1和CB2受体的优先信号配体，以及与人类疾病相关的其他受体靶点。通过其研发努力，该公司专注于医疗需求未得到满足的治疗领域，其项目涉及阿尔茨海默病、干性年龄相关性黄斑变性和大疱性表皮松解症等疾病。与其全资子公司BayMedica，LLC一起，InMed还开发专有制造方法，以在多个市场领域生产和商业化作为成分的散装稀有大麻素，从而保持在医药创新和基于大麻素的技术方面的地位。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.055524},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.102625},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.177592},{"month":4,"riseRate":0.666667,"avgChangeRate":0.079677},{"month":5,"riseRate":0.5,"avgChangeRate":0.150541},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.071204},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.111403},{"month":8,"riseRate":0.2,"avgChangeRate":0.013552},{"month":9,"riseRate":0.2,"avgChangeRate":-0.118637},{"month":10,"riseRate":0.2,"avgChangeRate":-0.198876},{"month":11,"riseRate":0.2,"avgChangeRate":-0.092328},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.132014}],"exchange":"NASDAQ","name":"InMed Pharmaceuticals Inc","nameEN":"InMed Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InMed Pharmaceuticals Inc(INM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InMed Pharmaceuticals Inc,INM,InMed Pharmaceuticals Inc股票,InMed Pharmaceuticals Inc股票老虎,InMed Pharmaceuticals Inc股票老虎国际,InMed Pharmaceuticals Inc行情,InMed Pharmaceuticals Inc股票行情,InMed Pharmaceuticals Inc股价,InMed Pharmaceuticals Inc股市,InMed Pharmaceuticals Inc股票价格,InMed Pharmaceuticals Inc股票交易,InMed Pharmaceuticals Inc股票购买,InMed Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InMed Pharmaceuticals Inc(INM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}